Robuta

https://www.biospace.com/press-releases/allarity-therapeutics-announces-expansion-of-phase-2-clinical-trial-to-accelerate-development-of-stenoparib-in-advanced-ovarian-cancer Allarity Therapeutics Announces Expansion of Phase 2 Clinical Trial to Accelerate Development of... phase 2 clinical trialexpansion of https://www.businesswire.com/news/home/20250122193446/en/Humanetics-Corporation-Announces-Positive-Phase-2-Clinical-Trial-Results-in-COVID-19-Study-Aimed-at-Improving-Pulmonary-Function Humanetics Corporation Announces Positive Phase 2 Clinical Trial Results in COVID-19 Study Aimed at... This release details preliminary results from a phase II clinical trial of BIO 300. phase 2 clinical trial https://www.prnewswire.com/news-releases/conatus-pharmaceuticals-terminates-phase-2-clinical-trial-of-cts-1027-132545253.html Conatus Pharmaceuticals Terminates Phase 2 Clinical Trial of CTS-1027 /PRNewswire/ -- Conatus Pharmaceuticals Inc. announced today the termination of its Phase 2 clinical trial of CTS-1027 in HCV patients. This decision follows... phase 2 clinical trialconatuspharmaceuticalscts1027 https://www.biospace.com/menlo-therapeutics-presents-successful-phase-2-clinical-trial-results-of-serlopitant-in-psoriasis-at-the-european-academy-of-dermatology-and-venereology-meeting Menlo Therapeutics Presents Successful Phase 2 Clinical Trial Results of Serlopitant in Psoriasis... Oct 11, 2019 - Menlo Therapeutics Inc. (Nasdaq: MNLO), a late-stage biopharmaceutical company, presented results from its successful Phase 2 clinical trial of serlopitant for... phase 2 clinical trial https://investingnews.com/daily/life-science-investing/pharmaceutical-investing/cytokinetics-announces-start-of-phase-2-clinical-trial-of-ck-3773274/ Cytokinetics Announces Start of Phase 2 Clinical Trial of CK-3773274 | INN Jan 2, 2026 - Cytokinetics (NASDAQ:CYTK) announced that REDWOOD-HCM (Randomized Evaluation of Dosing With CK-274 in Obstructive Outflow Disease in HCM) has opened to... phase 2 clinical trialcytokineticsannouncesstart https://www.biospace.com/hibercell-to-collaborate-with-merck-on-phase-2-clinical-trial-of-odetiglucan-in-combination-with-keytruda-pembrolizumab-in-patients-with-metastatic-breast-cancer HiberCell to Collaborate with Merck on Phase 2 Clinical Trial of Odetiglucan in Combination with... Dec 15, 2021 - HiberCell announced a clinical trial collaboration with Merck, known as MSD outside of the United States and Canada. phase 2 clinical trial https://www.biospace.com/entera-bio-ltd-announces-completion-of-enrollment-in-phase-2-clinical-trial-of-eb613-in-osteoporosis Entera Bio Ltd Announces Completion of Enrollment In Phase 2 Clinical Trial of Eb613 In... Nov 9, 2020 - Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of orally delivered large molecule therapeutics, announced the completion of enrollment in the... phase 2 clinical trial https://www.amgen.com/newsroom/press-releases/2006/06/final-results-of-phase-2-clinical-trial-program-suggest-treatment-of-anemia-with-aranespr-darbepoetin-alfa-may-decrease-risk-of-hospitalization-and-allcause-mortality-in-heart-failure-patients-with-anemia-based-on-a-prespecified-pooled-analysis Final Results of Phase 2 Clinical Trial Program Suggest Treatment of Anemia with Aranesp(R)... phase 2 clinical trial https://www.prnewswire.com/news-releases/altheus-therapeutics-announces-completed-enrollment-of-za201-a-phase-2-clinical-trial-of-zoenasa-for-distal-ulcerative-colitis-239419701.html Altheus Therapeutics announces completed enrollment of ZA201, a Phase 2 clinical trial of Zoenasa... /PRNewswire/ -- Altheus Therapeutics, Inc., announced that it has completed enrollment for ZA201, a 6-week, double-blind, active-controlled Phase 2 clinical... phase 2 clinical trial https://www.biospace.com/trialspark-announces-first-patient-dosed-in-phase-2-clinical-trial-for-asn008-201-in-atopic-dermatitis TrialSpark Announces First Patient Dosed in Phase 2 Clinical Trial for ASN008-201 in Atopic... May 23, 2023 - TrialSpark, Inc. announced today that the first patient has been dosed in its Phase 2 clinical trial for ASN008-201, a topical sodium channel blocker in... phase 2 clinical trial https://www.biospace.com/press-releases/cindome-pharma-announces-first-patient-dosed-in-the-envisiongi-phase-2-clinical-trial-of-deudomperidone-cin-102-for-the-treatment-of-idiopathic-gastroparesis CinDome Pharma Announces First Patient Dosed in the envisionGI Phase 2 Clinical Trial of... phase 2 clinical trial https://www.biospace.com/press-releases/igc-pharmas-phase-2-clinical-trial-interim-data-demonstrates-significant-reduction-in-sleep-disturbances IGC Pharma's Phase 2 Clinical Trial Interim Data Demonstrates Significant Reduction in Sleep... phase 2 clinical trial https://www.biospace.com/mc2-therapeutics-announces-initiation-of-a-phase-2-clinical-trial-in-ckd-ap MC2 Therapeutics announces initiation of a Phase 2 clinical trial in CKD-aP - BioSpace Sep 14, 2022 - MC2 Therapeutics A/S announces that the first patients have been dosed in its European Phase 2 trial, MC2-25-C1, evaluating the safety and efficacy of MC2-25... phase 2 clinical trial https://www.globenewswire.com/fr/news-release/2020/08/05/2073785/0/en/BioAegis-Therapeutics-Initiates-Phase-2-Clinical-Trial-of-Its-Inflammation-Regulator-Gelsolin-for-COVID-19-Treatment.html BioAegis Therapeutics Initiates Phase 2 Clinical Trial of MORRISTOWN, N.J., Aug. 05, 2020 (GLOBE NEWSWIRE) -- BioAegis Therapeutics Inc., a clinical stage, private company developing therapies for infectious,... phase 2 clinical trialtherapeuticsinitiates https://www.dana-farber.org/newsroom/news-releases/2023/dana-farber-leads-adaptive-efficient-multi-arm-phase-2-clinical-trial-for-glioblastoma Dana-Farber Leads Adaptive, Efficient Multi-arm Phase 2 Clinical Trial for Glioblastoma |... An innovative phase 2 clinical trial led by Dana-Farber Cancer Institute in collaboration with 10 major brain tumor centers around the country and designed to... phase 2 clinical trial https://www.biospace.com/agenebio-announces-publication-of-phase-2-clinical-trial-results-for-new-approach-to-delaying-the-onset-of-alzheimer-s-dementia AgeneBio Announces Publication Of Phase 2 Clinical Trial Results For New Approach To Delaying The... phase 2 clinical trial https://www.fiercebiotech.com/biotech/acceleron-pharma-initiates-phase-2-clinical-trial-ace-031-patients-duchenne-muscular Acceleron Pharma Initiates Phase 2 Clinical Trial with ACE-031 in Patients with Duchenne Muscular... May 7, 2010 - Acceleron Pharma Initiates Phase 2 Clinical Trial with ACE-031 in Patients with Duchenne Muscular Dystrophy Study will explore safety, tolerability and effects... phase 2 clinical trial https://www.businesswire.com/news/home/20201204005134/en/Magenta-Therapeutics-and-bluebird-bio-Announce-a-Phase-2-Clinical-Trial-Collaboration-to-Evaluate-Magentas-MGTA-145-for-Mobilizing-and-Collecting-Stem-Cells-in-Adults-and-Adolescents-with-Sickle-Cell-Disease Magenta Therapeutics and bluebird bio Announce a Phase 2 Clinical Trial Collaboration to Evaluate... Magenta Therapeutics (NASDAQ: MGTA) and bluebird bio, Inc. (NASDAQ: BLUE) today announced an exclusive clinical trial collaboration to evaluate the utility o... phase 2 clinical trial https://www.businesswire.com/news/home/20201201005539/en/Turnstone-Biologics-Announces-First-Patients-Enrolled-in-Phase-12-Clinical-Trial-Evaluating-RIVAL-01-For-the-Treatment-of-Solid-Tumors Turnstone Biologics Announces First Patients Enrolled in Phase 1/2 Clinical Trial Evaluating... Turnstone Biologics Corp., a clinical-stage biotechnology company pioneering the development of engineered viral immunotherapies, today announced enrollment ... https://www.biospace.com/press-releases/lyell-immunopharma-announces-oral-presentation-of-new-clinical-data-from-the-phase-1-2-trial-of-lyl314-for-the-treatment-of-large-b-cell-lymphoma-at-the-international-conference-on-malignant-lymphoma-icml-2025 Lyell Immunopharma Announces Oral Presentation of New Clinical Data from the Phase 1/2 Trial of...